Delineating the Spread and Prevalence of SARS-CoV-2 Omicron Sublineages (BA.1-BA.5) and Deltacron Using Wastewater in the Western Cape, South Africa.
B.1.5.9 (Omicron)
B.1.617.2 (Delta) lineages
BA.1
BA.2
BA.3
SARS-CoV-2
and BA.5
genotyping
wastewater-based epidemiology
Journal
The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675
Informations de publication
Date de publication:
17 10 2022
17 10 2022
Historique:
received:
24
05
2022
accepted:
24
08
2022
pubmed:
27
8
2022
medline:
19
10
2022
entrez:
26
8
2022
Statut:
ppublish
Résumé
This study was one of the first to detect Omicron sublineages BA.4 and BA.5 in wastewater from South Africa. Spearman rank correlation analysis confirmed a strong positive correlation between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA in wastewater samples and clinical cases (r = 0.7749, P < .0001). SARS-CoV-2 viral load detected in wastewater, resulting from the Delta-driven third wave, was significantly higher than during the Omicron-driven fourth wave. Whole-genome sequencing confirmed presence of Omicron lineage defining mutations in wastewater with the first occurrence reported 23 November 2021 (BA.1 predominant). The variant spread rapidly, with prevalence of Omicron-positive wastewater samples rising to >80% by 10 January 2022 with BA.2 as the predominant sublineage by 10 March 2022, whilst on 18 April 2022 BA.4 and BA.5 were detected in selected wastewater sites. These findings demonstrate the value of wastewater-based epidemiology to monitor the spatiotemporal spread and potential origin of new Omicron sublineages.
Identifiants
pubmed: 36017801
pii: 6677087
doi: 10.1093/infdis/jiac356
pmc: PMC9574669
doi:
Substances chimiques
RNA, Viral
0
Waste Water
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1418-1427Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Déclaration de conflit d'intérêts
Potential conflicts of interest. All authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. The authors have no conflicts of interest to declare.
Références
Viruses. 2022 Mar 04;14(3):
pubmed: 35336939
Sci Total Environ. 2022 Oct 20;844:156932
pubmed: 35753493
J Med Virol. 2022 Apr;94(4):1728-1733
pubmed: 34897752
Lancet. 2022 Apr 23;399(10335):1618-1624
pubmed: 35397851
J Med Virol. 2022 May;94(5):1777-1779
pubmed: 34964502
Lancet. 2022 Jan 29;399(10323):437-446
pubmed: 35065011
Cell. 2022 Apr 28;185(9):1556-1571.e18
pubmed: 35447072
One Health. 2020 Dec;10:100157
pubmed: 32835069
Sci Total Environ. 2022 Aug 25;836:155599
pubmed: 35504376
J Med Virol. 2022 May;94(5):1808-1810
pubmed: 35043399
Int J Environ Res Public Health. 2021 Nov 17;18(22):
pubmed: 34831841
Nat Commun. 2022 May 18;13(1):2745
pubmed: 35585202
Sci Total Environ. 2021 Jun 25;775:145790
pubmed: 33618308
Environ Res. 2022 Jun;209:112816
pubmed: 35093310
Sci Total Environ. 2022 Jan 15;804:150151
pubmed: 34623953
Trop Med Int Health. 2022 Jun;27(6):564-573
pubmed: 35411997
Nature. 2022 Mar;603(7902):679-686
pubmed: 35042229
J Med Virol. 2022 Oct;94(10):4780-4791
pubmed: 35680610
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):146-152
pubmed: 35085225
Sci Total Environ. 2022 Oct 1;841:156741
pubmed: 35716745
Sci Total Environ. 2021 Jul 20;779:146408
pubmed: 33743467
Nature. 2022 Mar 4;:
pubmed: 35246640
Science. 2022 May 6;376(6593):eabn4947
pubmed: 35289632
Sci Total Environ. 2022 Nov 20;848:157740
pubmed: 35917966
Sci Rep. 2022 Jan 21;12(1):1182
pubmed: 35064174
Travel Med Infect Dis. 2022 Mar-Apr;46:102252
pubmed: 34973454
Nat Rev Immunol. 2022 May;22(5):267-269
pubmed: 35414124
S Afr Med J. 2021 Jan 28;111(3):198-202
pubmed: 33944737
Sci Total Environ. 2020 Sep 20;736:139652
pubmed: 32464333
Sci Total Environ. 2022 Jan 20;805:150121
pubmed: 34534872
Nat Biotechnol. 2020 Oct;38(10):1164-1167
pubmed: 32948856
J Med Virol. 2022 Jun;94(6):2376-2383
pubmed: 35118687